20
Participants
Start Date
March 1, 2025
Primary Completion Date
March 1, 2026
Study Completion Date
March 1, 2027
Combination Product:t: SIRT-Y90 +HAIC+Atezolizumab + Bevacizumab
"Single or two-staged delivery of SIRT-Y90 (4 to 6 weeks), followed by 1200mg atezolizumab + 15mg/kg bevacizumab administered by IV at every 3 weeks for 18 months.~HAIC:administration of oxaliplatin , fluorouracil, and leucovorin via the tumor feeding arteries every 3 weeks."
Tianjin Medical University Cancer Institute and Hospital
OTHER